Medical Historical Cash Flow

MPW Stock

USD 4.33 0.07 1.64%

Analysis of Medical Properties cash flow over time is an excellent tool to project Medical Properties Trust future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 259.2 M or Other Cashflows From Financing Activities of 14.5 M as it is a great indicator of Medical Properties ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Medical Properties Trust latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medical Properties Trust is a good buy for the upcoming year.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

About Medical Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Medical balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Medical's non-liquid assets can be easily converted into cash.

Medical Properties Cash Flow Chart

At this time, Medical Properties' Total Cashflows From Investing Activities is fairly stable compared to the past year. Other Cashflows From Investing Activities is likely to climb to about 2.3 B in 2024, whereas Change In Cash is likely to drop slightly above 10.2 M in 2024.

Begin Period Cash Flow Dividends Paid Capital Expenditures End Period Cash Flow

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Medical Properties Trust to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Medical Properties operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most accounts from Medical Properties' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Medical Properties Trust current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

	2021	2022	2023	2024 (projected)
Capital Expenditures	65.5M	1.3B	529.4M	756.4M
Dividends Paid	643.5M	698.5M	615.4M	646.2M

Capital Expenditures Dividends Paid

Medical Properties cash flow statement Correlations

	Sale Purchase Of Stock	Change To Inventory	Change In Cash	Free Cash Flow	Change In Working Capital	Begin Period Cash Flow	Depreciation	Other Non Cash Items	Dividends Paid	Capital Expenditures	Change To Account Receivables	Net Income	End Period Cash Flow	Change To Liabilities	Stock Based Compensation	Investments	Net Borrowings	Cash And Cash Equivalents Changes	Cash Flows Other Operating	Change To Netincome	Exchange Rate Changes	Change To Operating Activities	Issuance Of Capital Stock
Sale Purchase Of Stock		-0.41	0.0	-0.09	0.36	0.52	-0.02	-0.35	0.29	0.28	0.35	0.39	0.54	0.07	0.45	0.56	0.94	0.07	-0.64	0.38	0.34	0.15	0.67
Change To Inventory	-0.41		-0.19	0.37	-0.73	-0.03	0.87	0.47	0.66	0.0	-0.94	-0.35	-0.21	0.4	0.41	-0.25	-0.56	-0.32	-0.17	-0.63	0.51	-0.01	-0.36
Change In Cash	0.0	-0.19		-0.32	0.1	-0.48	-0.19	0.13	-0.24	-0.51	0.26	0.09	0.44	0.2	-0.36	-0.42	0.08	0.98	0.42	-0.32	0.01	-0.65	0.35
Free Cash Flow	-0.09	0.37	-0.32		-0.11	0.42	0.43	0.03	0.42	-0.33	-0.39	-0.09	0.14	0.36	0.54	0.15	-0.14	-0.36	-0.5	-0.01	0.33	0.31	0.26
Change In Working Capital	0.36	-0.73	0.1	-0.11		0.24	-0.72	-0.89	-0.32	0.07	0.75	0.77	0.34	-0.23	0.05	0.29	0.48	0.27	-0.05	0.36	-0.3	0.04	0.41
Begin Period Cash Flow	0.52	-0.03	-0.48	0.42	0.24		0.3	-0.26	0.57	0.58	0.02	0.3	0.58	-0.08	0.76	0.56	0.48	-0.45	-0.72	0.15	0.49	0.5	0.51
Depreciation	-0.02	0.87	-0.19	0.43	-0.72	0.3		0.53	0.87	0.14	-0.84	-0.31	0.13	0.47	0.61	0.05	-0.21	-0.33	-0.47	-0.53	0.72	0.0	-0.02
Other Non Cash Items	-0.35	0.47	0.13	0.03	-0.89	-0.26	0.53		0.08	-0.17	-0.48	-0.86	-0.14	0.18	-0.27	-0.33	-0.38	-0.04	0.18	-0.23	0.14	-0.09	-0.22
Dividends Paid	0.29	0.66	-0.24	0.42	-0.32	0.57	0.87	0.08		0.33	-0.62	0.16	0.37	0.41	0.87	0.3	0.08	-0.3	-0.67	-0.49	0.83	0.02	0.2
Capital Expenditures	0.28	0.0	-0.51	-0.33	0.07	0.58	0.14	-0.17	0.33		0.05	0.26	0.11	-0.51	0.32	0.35	0.2	-0.48	-0.2	-0.04	0.26	0.37	-0.16
Change To Account Receivables	0.35	-0.94	0.26	-0.39	0.75	0.02	-0.84	-0.48	-0.62	0.05		0.47	0.27	-0.52	-0.37	0.31	0.47	0.4	0.2	0.42	-0.42	-0.03	0.28
Net Income	0.39	-0.35	0.09	-0.09	0.77	0.3	-0.31	-0.86	0.16	0.26	0.47		0.39	-0.19	0.37	0.44	0.33	0.23	-0.18	-0.18	0.17	-0.18	0.24
End Period Cash Flow	0.54	-0.21	0.44	0.14	0.34	0.58	0.13	-0.14	0.37	0.11	0.27	0.39		0.1	0.44	0.19	0.56	0.46	-0.34	-0.15	0.51	-0.09	0.84
Change To Liabilities	0.07	0.4	0.2	0.36	-0.23	-0.08	0.47	0.18	0.41	-0.51	-0.52	-0.19	0.1		0.33	0.0	0.05	0.14	-0.4	-0.11	0.14	-0.39	0.33
Stock Based Compensation	0.45	0.41	-0.36	0.54	0.05	0.76	0.61	-0.27	0.87	0.32	-0.37	0.37	0.44	0.33		0.49	0.31	-0.37	-0.85	-0.19	0.69	0.27	0.38
Investments	0.56	-0.25	-0.42	0.15	0.29	0.56	0.05	-0.33	0.3	0.35	0.31	0.44	0.19	0.0	0.49		0.42	-0.35	-0.69	0.19	0.12	0.09	0.19
Net Borrowings	0.94	-0.56	0.08	-0.14	0.48	0.48	-0.21	-0.38	0.08	0.2	0.47	0.33	0.56	0.05	0.31	0.42		0.15	-0.54	0.55	0.15	0.24	0.77
Cash And Cash Equivalents Changes	0.07	-0.32	0.98	-0.36	0.27	-0.45	-0.33	-0.04	-0.3	-0.48	0.4	0.23	0.46	0.14	-0.37	-0.35	0.15		0.42	-0.25	-0.07	-0.64	0.38
Cash Flows Other Operating	-0.64	-0.17	0.42	-0.5	-0.05	-0.72	-0.47	0.18	-0.67	-0.2	0.2	-0.18	-0.34	-0.4	-0.85	-0.69	-0.54	0.42		-0.2	-0.45	-0.34	-0.48
Change To Netincome	0.38	-0.63	-0.32	-0.01	0.36	0.15	-0.53	-0.23	-0.49	-0.04	0.42	-0.18	-0.15	-0.11	-0.19	0.19	0.55	-0.25	-0.2		-0.53	0.51	0.28
Exchange Rate Changes	0.34	0.51	0.01	0.33	-0.3	0.49	0.72	0.14	0.83	0.26	-0.42	0.17	0.51	0.14	0.69	0.12	0.15	-0.07	-0.45	-0.53		0.06	0.29
Change To Operating Activities	0.15	-0.01	-0.65	0.31	0.04	0.5	0.0	-0.09	0.02	0.37	-0.03	-0.18	-0.09	-0.39	0.27	0.09	0.24	-0.64	-0.34	0.51	0.06		0.03
Issuance Of Capital Stock	0.67	-0.36	0.35	0.26	0.41	0.51	-0.02	-0.22	0.2	-0.16	0.28	0.24	0.84	0.33	0.38	0.19	0.77	0.38	-0.48	0.28	0.29	0.03

Click cells to compare fundamentals

Medical Properties Account Relationship Matchups

Medical Properties cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Sale Purchase Of Stock	3.0B	2.4B	4.0B	(47.9M)	(8.1M)	(7.7M)
Change To Inventory	(39.6M)	2.4M	23.9M	116.4M	133.9M	140.6M
Change In Cash	645.6M	(911.6M)	(94.5M)	(220.3M)	14.4M	10.2M
Free Cash Flow	494.1M	617.6M	746.1M	739.0M	505.8M	531.1M
Change In Working Capital	53.1M	17.2M	13.1M	29.6M	(125.0M)	(118.8M)
Begin Period Cash Flow	822.4M	1.5B	556.4M	461.9M	241.5M	259.2M
Other Cashflows From Financing Activities	(62.3M)	(20.6M)	(36.7M)	273.5M	15.3M	14.5M
Depreciation	156.6M	276.0M	333.8M	345.6M	616.1M	646.9M
Other Non Cash Items	(103.6M)	(176.8M)	(287.0M)	(600.1M)	706.9M	742.2M
Dividends Paid	411.7M	568.0M	643.5M	698.5M	615.4M	646.2M
Capital Expenditures	28.0M	4.2B	65.5M	1.3B	529.4M	756.4M
Total Cash From Operating Activities	494.1M	617.6M	811.7M	739.0M	505.8M	287.9M
Change To Account Receivables	12.9M	(2.4M)	(23.9M)	(116.4M)	(141.7M)	(134.6M)
Net Income	376.4M	432.3M	656.9M	903.8M	(558.1M)	(530.2M)
Total Cash From Financing Activities	5.0B	1.4B	2.9B	(1.3B)	(1.0B)	(969.3M)
End Period Cash Flow	1.5B	556.4M	461.9M	241.5M	256.0M	273.2M
Change To Liabilities	39.6M	(18.4M)	54.1M	33.6M	38.6M	40.5M
Stock Based Compensation	32.2M	47.2M	52.1M	49.4M	33.3M	21.4M
Total Cashflows From Investing Activities	(4.9B)	(2.9B)	(3.9B)	396.1M	356.5M	374.3M
Investments	(53.2M)	1.3B	1.6B	(139.9M)	(114.9M)	(109.2M)
Net Borrowings	3.0B	1.6B	2.6B	(537.5M)	(618.1M)	(587.2M)
Cash And Cash Equivalents Changes	652.0M	(928.1M)	(99.1M)	(207.5M)	(186.7M)	(177.4M)
Cash Flows Other Operating	(103.7M)	(171.7M)	(261.5M)	(79.8M)	(71.8M)	(75.4M)
Other Cashflows From Investing Activities	(265.2M)	(10.4M)	(110.5M)	1.9B	2.1B	2.3B
Change To Netincome	16.3M	86.4M	11.6M	(481.2M)	(433.1M)	(411.4M)
Change To Operating Activities	(5.0M)	18.3M	(4.4M)	(4.0M)	(4.6M)	(4.9M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Medical Stock Analysis

When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medical Historical Cash Flow

About Medical Cash Flow Analysis

Medical Properties Cash Flow Chart

Begin Period Cash Flow

Dividends Paid

Capital Expenditures

Medical Properties cash flow statement Correlations

Medical Properties Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Medical Properties cash flow statement Accounts

Also Currently Popular

Additional Tools for Medical Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Cash Equivalents Changes	+ 0.98	Change In Cash
Net Borrowings	+ 0.94	Sale Purchase Of Stock
Depreciation	+ 0.87	Change To Inventory
Dividends Paid	+ 0.87	Depreciation
Stock Based Compensation	+ 0.87	Dividends Paid
Issuance Of Capital Stock	+ 0.84	End Period Cash Flow

Change To Account Receivables	- 0.94	Change To Inventory
Other Non Cash Items	- 0.89	Change In Working Capital
Net Income	- 0.86	Other Non Cash Items
Cash Flows Other Operating	- 0.85	Stock Based Compensation
Change To Account Receivables	- 0.84	Depreciation
Change In Working Capital	- 0.73	Change To Inventory